Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Sale
Common Stock
2024-01-08$28.04/sh−1,019$28,568→ 105,254 total
Footnotes (1)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.